Medpace shares plunge after weak bookings and earnings miss raise growth concerns

Medpace's stock fell sharply following a disappointing quarterly earnings report driven by weak bookings and increased cancellations, which have reduced the company's backlog. This trend raises concerns about Medpace's near-term growth and operational momentum, prompting investors to reconsider the company's valuation and future expectations. The market's reaction highlights heightened sensitivity to the company's quarterly performance and execution risks going forward.